Wall Street's major averages dipped for the week as investors wrestled with tariff twists from the Trump administration. The ...
A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight ...
As earnings season begins, filings to the SEC point to uncertainty from the current administration as potential trouble for ...
In his final game as a head coach, Tom Lilly ended his 40-plus year career with a win, coaching Xavier to their sixth state championship, with a 66-47 win over North Polk.
Hims & Hers generated $1.5 billion in revenue in 2024, reflecting a 69% year-over-year increase. See why I rate HIMS stock a ...
Novo Nordisk says many Australians would be willing to pay the out-of-pocket costs for its blockbuster medicines, which can ...
For 40 seasons, Tom Lilly has built a legacy on the sidelines. In his final game as head coach, his Xavier Saints made sure he went out on top. Behind a histori ...
What's considered excellent revenue growth depends on the industry. For pharmaceutical companies, especially those with a ...
The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...
What's considered excellent revenue growth depends on the industry. With that context in mind, consider that Eli Lilly's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback